Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Reversibility of trastuzumab cardiotoxicity: Is the concept alive and well? Reply JOURNAL OF CLINICAL ONCOLOGY Telli, M. L., Carlson, R. W., Guardino, A. E., Hunt, S. A., Witteles, R. M. 2007; 25 (34): 5533-5534
View details for DOI 10.1200/JCO.2007.14.1036
View details for Web of Science ID 000253885700032